Sahetya Medical Group

CLIA Laboratory Citation Details

3
Total Citations
24
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 18D0705936
Address 1573 Ky Hwy 259 N, Brownsville, KY, 42210
City Brownsville
State KY
Zip Code42210
Phone(270) 597-2168

Citation History (3 surveys)

Survey - August 8, 2025

Survey Type: Special

Survey Event ID: PWBX11

Deficiency Tags: D0000 D2016 D2130 D6000 D6016 D0000 D2016 D2130 D6000 D6016

Summary:

Summary Statement of Deficiencies D0000 A Proficiency Testing (PT) Desk Review was conducted on August 8, 2025 by the Kentucky Office of Inspector General/Division of Healthcare. The laboratory was found to be out of compliance with the conditions of the CLIA program. The following CONDITION LEVEL DEFICIENCIES were found to be out of compliance: D2016 - 42 C.F.R. 493.803 Condition: Successful participation [proficiency testing] D6000 - 42 C.F.R. 493.1403 Condition: Laboratories performing moderate complexity testing; laboratory director D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on a Proficiency Testing (PT) Desk Review of the Certification and Survey Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- Provider Enhanced Reporting (CASPER)-0155 and Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing 2025 PT records (1st and 2nd events), the laboratory failed to successfully participate in a PT program for two consecutive PT testing events for White Blood Cell (WBC) Differential. (Refer to D2130). D2130 HEMATOLOGY CFR(s): 493.851(f) (f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on a Proficiency Testing (PT) Desk Review of the Certification and Survey Provider Enhanced Reporting (CASPER)-0155 and Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing 2025 PT records (1st and 2nd events), the laboratory failed to achieve satisfactory performance (80% or greater) for two consecutive testing events in the specialty of Hematology for White Blood Cell (WBC) Differential. 1. Review of the CASPER-0155 report revealed the following: Hematology 2025- 1st Event The Laboratory received an unsatisfactory score of 47% for WBC Differential. Hematology 2025- 2nd Event The Laboratory received an unsatisfactory score of 67% for WBC Differential. 2. A PT desk review from WSLH Proficiency Testing 2025 PT records confirmed the above findings. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on a Proficiency Testing (PT) Desk Review of the Certification and Survey Provider Enhanced Reporting (CASPER)-0155 and Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing 2025 PT records (1st and 2nd events), the laboratory director failed to provide overall management and direction of the laboratory services to ensure successful PT participation for two consecutive testing events for White Blood Cell (WBC) Differential. (Refer to D6016). D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) (e)(4)(i) The proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on a Proficiency Testing (PT) Desk Review of the Certification and Survey Providers Enhanced Reporting (CASPER)-0155 and Wisconsin State Laboratory of Hygiene (WLSH) Proficiency Testing 2025 PT records (1st and 2nd events), the -- 2 of 3 -- laboratory director failed to ensure that the PT samples were tested as required under Subpart H during two consecutive testing events for White Blood Cell (WBC) Differential. (Refer to 2130). -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 13, 2024

Survey Type: Special

Survey Event ID: 4VCR11

Deficiency Tags: D0000 D2016 D2130 D6000 D6016 D0000 D2016 D2130 D6000 D6016

Summary:

Summary Statement of Deficiencies D0000 The following deficiencies are a result of a desk review of proficiency testing (PT) scores obtained from the national database and verified with the proficiency testing company. The laboratory was found to be out of compliance with the conditions of the CLIA program. The following CONDITION LEVEL DEFICIENCIES were found to be out of compliance: D2016 - 42 C.F.R. 493.803 Condition: Successful participation [proficiency testing] D6000 - 42 C.F.R. 493.1403 Condition: Laboratories performing moderate complexity testing; laboratory director D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on a PT desk review of the Certification and Survey Provider Enhanced Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Reporting (CASPER)-0155 and Wisconsin State Laboratory of Hygiene (WSLH) PT 2023 records (2nd event) and 2024 records (1st event), the laboratory failed to successfully participate in a PT program approved by HHS, for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. The laboratory failed to successfully participate in the specialty of Hematology for the Platelets analyte. (Refer to D2130) D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on a PT desk review of the CASPER-0155 and WSLH PT records 2023 (2nd event) and 2024 (1st event), the laboratory failed to achieve satisfactory performance (80% or greater) for 2 of 3 testing events in the specialty of Hematology for the Platelets analyte. 1. A Review of the CASPER-0155 report revealed the following: Hematology 2023- 2nd Event The Laboratory received an unsatisfactory score of 20% for the Platelets analyte. Hematology 2024- 1st Event The Laboratory received an unsatisfactory score of 60% for the Platelets analyte. 2. A review of PT records (2023 and 2024) from WSLH confirmed the above findings. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on a PT desk review of the CASPER-0155 Individual Laboratory Report and WSLH PT records 2023 (2nd event) and 2024 (1st event), the laboratory director failed to provide overall management and direction of the laboratory services. (Refer to D6016) D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on a PT desk review of the CASPER-0155 and WSLH PT records 2023 (2nd event) and 2024 (1st event), the laboratory director failed to ensure successful participation in an HHS approved PT program. (Refer to 2130) -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 21, 2023

Survey Type: Standard

Survey Event ID: 9CBZ11

Deficiency Tags: D0000 D5415 D0000 D5415

Summary:

Summary Statement of Deficiencies D0000 A Recertification Survey was initiated and concluded on 08/21/2023. The facility was found not to be in compliance with the laboratory requirements of 42 CFR Part 493 with deficiencies cited. D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on observation, document review and interview, the laboratory failed to ensure quality control materials for the hematology analyzer were labeled with an open vial stability expiration date. The Findings include: During an observation, on 08/21/2023 at 11:00 AM, the Cell-Dyn quality controls currently in use for the hematology analyzer, were not labeled with an open vial stability expiration date. Review of the undated package insert labeled, "Cell-Dyn 18 Plus Control," revealed "Once opened, containers can be used only for the number of days stated on the assay sheet." Review of the undated "Cell-Dyn 18 Plus Control Assay Sheet", stated "8 Consecutive-Day Open-Tube Stability." In an interview on 08/21/2023 at 11:15 AM, Testing Personnel #1 confirmed she did not label the quality control vials with the opened vial stability expiration date. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access